Using SDTM Data to Produce Patient Narratives Blog Post
In this blog, we look at how medical writers can use SDTM data produced by BioStats teams to prepare high quality patient narratives.
How to Use Fix Tips for Better Clinical Data Issue Management Blog Post
Julie Ann Hood Principal Consultant April 15, 2025 Clinical data issue management: the basics Prior to submission to any regulatory agency, standardized study data is evaluated using at least one validation tool to ensure...
Using cost-effectiveness models for smarter drug development and healthcare decisions Blog Post
Noemi Hummel Mohsen Yaghoubi April 14, 2025 Editor’s note: This is the second in a series of four articles on the crucial role health economic modeling plays in evaluating the...
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing Blog Post
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies RADNOR, PA —April 14, 2025 – Certara, Inc. (Nasdaq: CERT),...
Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization Blog Post
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, PA — April 14, 2025 - Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today...
Non-Animal Navigator Page
Expert strategy and AI-enabled biosimulation to reduce, refine, or replace animal studies
Are you prepared for the FDA’s phase out of animal tests for mAbs? Blog Post
Speakers: Fran Brown, PhD Senior Vice President, Certara Drug Development Solutions Fran has over 25 years of experience with strategic and operational global drug development from early discovery to filing...
Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling Blog Post
June 10, 2025 – 11am ET
